News

McBean served at Covidien’s Specialty Pharmaceuticals as vice president and general manager from March 2009 until May 2011 and was responsible for executing a successful turnaround of the

The company’s patented PLX cells release therapeutic proteins in response to a host of local and systemic inflammatory diseases. PLX cells are grown using the company’s proprietary 3D

The patent provides protection for co-delivery technology that is used in the company’s ImuXen product range. The patent covers a method which deals with packaging a protein vaccine

So far, Alliance has acquired the rights to more than 50 pharmaceutical products. The company distributes its products through wholesalers, retail pharmacies, hospitals and an international network of

Zelboraf is indicated as a treatment for patients with unresectable or metastatic melanoma with BRAFV600E mutation. Biologics will administer the Patient Partners program, a clinical support service through

The JV, registered in Kuwait as Avita Medical Mena (AVM), will be 70% controlled by Avita Medical. AVM will be responsible for sales and marketing efforts in the

Sirolimus is currently being evaluated in a Phase III study entitled ‘study assessing double-masked uveitis treatment’ (Sakura) to evaluate the safety and efficacy of different doses of sirolimus.

The company expects to recruit around 1,200 patients with severe TBI (Glasgow Coma Scale scores of 4-8), who have sustained a closed-head trauma in SyNAPSe trial. The results

Thionyl chloride is an intermediate used by industrial customers to manufacture agrochemicals, dyestuffs, fine chemicals and pharmaceuticals. The company expects to complete the expansion in the second half